Kidney Diseases Associated With Anti-Vascular Endothelial Growth Factor (VEGF): An 8-year Observational Study at a Single Center

Expanded clinical experience with patients taking antiangiogenic compounds has come with increasing recognition of the renal adverse effects. Because renal histology is rarely sought in those patients, the renal consequences are underestimated. Antiangiogenic-treated-cancer patients, who had a renal...

Descripción completa

Detalles Bibliográficos
Autores principales: Izzedine, Hassan, Escudier, Bernard, Lhomme, Catherine, Pautier, Patricia, Rouvier, Philippe, Gueutin, Victor, Baumelou, Alain, Derosa, Lisa, Bahleda, Rastilav, Hollebecque, Antoine, Sahali, Djillali, Soria, Jean Charles
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2014
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4602430/
https://www.ncbi.nlm.nih.gov/pubmed/25500702
http://dx.doi.org/10.1097/MD.0000000000000207

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4602430/
https://www.ncbi.nlm.nih.gov/pubmed/25500702
http://dx.doi.org/10.1097/MD.0000000000000207

Ejemplares similares